Free Trial
NASDAQ:VMD

Viemed Healthcare (VMD) Stock Price, News & Analysis

Viemed Healthcare logo
$8.94 -0.27 (-2.93%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$8.95 +0.01 (+0.11%)
As of 05/8/2026 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Viemed Healthcare Stock (NASDAQ:VMD)

Advanced

Key Stats

Today's Range
$8.85
$9.16
50-Day Range
$8.40
$10.05
52-Week Range
$5.93
$10.18
Volume
248,589 shs
Average Volume
253,873 shs
Market Capitalization
$342.76 million
P/E Ratio
24.16
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Viemed Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

VMD MarketRank™: 

Viemed Healthcare scored higher than 47% of companies evaluated by MarketBeat, and ranked 520th out of 857 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Viemed Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Viemed Healthcare has received no research coverage in the past 90 days.

  • Read more about Viemed Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Viemed Healthcare are expected to grow by 30.43% in the coming year, from $0.46 to $0.60 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Viemed Healthcare is 24.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.23.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Viemed Healthcare is 24.16, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.19.

  • Price to Book Value per Share Ratio

    Viemed Healthcare has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.14% of the float of Viemed Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Viemed Healthcare has a short interest ratio ("days to cover") of 1.24, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Viemed Healthcare has recently decreased by 10.04%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Viemed Healthcare does not currently pay a dividend.

  • Dividend Growth

    Viemed Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Viemed Healthcare has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Viemed Healthcare this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for VMD on MarketBeat in the last 30 days.
  • MarketBeat Follows

    4 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Viemed Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,237,976.00 in company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Viemed Healthcare's insider trading history.
Receive VMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VMD Stock News Headlines

One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
See More Headlines

VMD Stock Analysis - Frequently Asked Questions

Viemed Healthcare's stock was trading at $7.43 at the beginning of the year. Since then, VMD shares have increased by 20.3% and is now trading at $8.94.

Viemed Healthcare, Inc. (NASDAQ:VMD) posted its quarterly earnings results on Tuesday, May, 5th. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by $0.03. The business earned $75.41 million during the quarter, compared to analyst estimates of $74.40 million. Viemed Healthcare had a trailing twelve-month return on equity of 10.52% and a net margin of 5.20%.
Read the conference call transcript
.

Viemed Healthcare's top institutional shareholders include Hillsdale Investment Management Inc. (0.52%), Dimensional Fund Advisors LP (0.49%), North Star Investment Management Corp. (0.26%) and Bank of New York Mellon Corp (0.21%). Insiders that own company stock include Michael Moore, Nitin Kaushal, Randy E Dobbs, Jerome Cambre, Timothy Smokoff and Sabrina Heltz.
View institutional ownership trends
.

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

Last Earnings
5/05/2026
Today
5/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:VMD
CIK
1729149
Fax
N/A
Employees
1,382
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
$0.37
Trailing P/E Ratio
24.16
Forward P/E Ratio
19.43
P/E Growth
N/A
Net Income
$14.93 million
Net Margins
5.20%
Pretax Margin
7.71%
Return on Equity
10.52%
Return on Assets
7.60%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
1.22
Quick Ratio
1.06

Sales & Book Value

Annual Sales
$270.28 million
Price / Sales
1.27
Cash Flow
$1.15 per share
Price / Cash Flow
7.76
Book Value
$3.80 per share
Price / Book
2.35

Miscellaneous

Outstanding Shares
38,340,000
Free Float
30,670,000
Market Cap
$342.76 million
Optionable
Not Optionable
Beta
1.15

Social Links

Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:VMD) was last updated on 5/10/2026 by MarketBeat.com Staff.
From Our Partners